‘Promoting a sensible policy towards medicinal cannabis in the EU27’: this is the mission of the European Alliance for Medicinal Cannabis (EAMC).
The European Alliance for Medicinal Cannabis (EAMC) is the Brussels-based, industry-led organisation representing medical cannabis licensed producers across the European Union.
On 9 February 2020, EAMC hosted a networking event with around +50 invited industry delegates, ahead of the Cannabis Europa conference in Madrid.
Bringing the European cannabis industry together
The gathering was the occasion to reaffirm EAMC’s ambition to bring the cannabis industry together under one umbrella organisation and advocate in favour of a harmonised regulatory framework on medicinal cannabis at EU level, making use of the association’s wide expertise and extensive network within the EU institutions and Member States. Ultimately, such a framework would enable the industry to thrive under a clear and well-regulated market.
Helene Moore (EAMC board member and Director General of Aurora France), illustrated the current challenges faced by the medicinal cannabis industry, such as standard compliance, regulatory fragmentation and lack of sufficient public funded research on medicinal cannabis.
In order to contribute concretely in shaping future EU policies, EAMC is currently working with its members on a medicinal cannabis manifesto, which will identify regulatory solutions that could be implemented by European policymakers.
James O’Dowd, EAMC Secretary General, emphasised: “Interest in medicinal cannabis is gaining ground throughout the European Union. Society, policymakers, patients and scientific institutions are acknowledging the need for a well-regulated medicinal cannabis market in the EU.
“It is of upmost importance to harmonise the regulatory framework at European level to ensure patients’ fair access to medicinal cannabis and to maintain the integrity of the single market as more EU Member States adopt access programmes”.
